03:55:52 Europe / Stockholm

Prenumeration

2023-03-01 10:58:00

Redeye provides a research update following Penneo’s Q4 2022 report. The ARR aligned with preliminary figures, while the EBITDA was slightly above our expectations. Penneo also revealed its full-year 2023 ARR and EBITDA guidance in connection with the report, implying continued solid growth. Accordingly, we take a stance on this and make estimate changes that have a slight effect on our valuation.

Read more and download the Research Update.

Follow companies at Redeye to receive the latest equity research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/